Venous Thromboembolism & Anticoagulation
Noon Conference
Test your smarts about VTE and Anticoagulation.
View the presentation linked here.
Thrombophilia Testing and Venous Thrombosis
EBM, Landmark Research
Do patients with venous thrombosis require testing for inherited thrombophilia? Read the expert consensus in this review article. Here are some questions you should answer from this article: Why checking for inherited thrombophilia not clinically useful? What factors should determine…
Oral Apixaban for the Treatment of Acute Venous Thromboembolism (AMPLIFY)
EBM, Landmark Research
LMWH versus Warfarin for the Prevention of Recurrent VTE in Patients with Cancer (CLOT Trial)
EBM, Landmark Research
Low-molecular-weight heparin (LMWH) rather than warfarin is routinely recommended for patients with venous thromboembolism (VTE) and active cancer. Much of that is based on this article. Think about these as you review the article: Clinical Question: In patients with cancer…
Einstein Choice: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
EBM, Journal Club
Clinical Question In patients who would benefit from continued anti-coagulation is treatment dose rivaroxaban vs thromboprophylactic dose as effective as aspirin for prevention of recurrent thromboembolism? Bottom Line Rivaroxaban at both treatment dose (20mg) and a thromboprophylactic dose (10mg), was…